Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999750613> ?p ?o ?g. }
- W2999750613 endingPage "487" @default.
- W2999750613 startingPage "477" @default.
- W2999750613 abstract "This study is aimed at analyzing the impact of the main factors contributing to short and long-term mortality in patients at final stages of heart failure (HF). Patients attended at any of the 279 primary health care centers belonging to the Institut Català de la Salut, in Catalonia (Spain). Patients with Advanced HF. Multicenter cohort study including 1148 HF patients followed for one-year after reaching New York Heart Association (NYHA) IV. The primary outcome was all-cause mortality. Multivariate logistic regression models were performed to assess the outcomes at 1, 3, 6, and 12 months. Mean age of patients was 82 (SD 9) years and women represented 61.7%. A total of 135 (11.8%) and 397 (34.6%) patients died three months and one year after inclusion, respectively. Male gender, age, and decreased body mass index were associated with higher mortality at three, six and twelve months. In addition, low systolic blood pressure levels, severe reduction in glomerular filtration, malignancy, and higher doses of loop diuretics were related to higher mortality from 6 to 12 months. The most important risk factor over the whole period was presenting a body mass index lower than 20 kg/m2 (three months OR 3.06, 95% CI: 1.58–5.92; six months OR 4.42, 95% CI: 2.08–9.38; and 12 months OR 3.68, 95% CI: 1.76–7.69). We may conclude that male, age, and decreased body mass index determined higher short-term mortality in NYHA IV. In addition, low systolic blood pressure, reduced glomerular filtration, malignancy, and higher doses of loop diuretics contribute to increasing the risk of mortality at medium and long-term. Such variables are easily measurable and can help to decide the best way to face the most advances stages of the disease. Analizar los factores que contribuyen a la mortalidad de pacientes en las etapas finales de la insuficiencia cardiaca (IC). Centros de atención primaria del Institut Català de la Salut, Cataluña, España. Pacientes con IC avanzada. Estudio de cohortes multicéntrico. Incluyó 1.148 pacientes de IC seguidos durante un año tras el registro de estadio funcional NYHA IV. El resultado principal fue la mortalidad por todas las causas. Se realizaron modelos de regresión logística multivariada (1, 3, 6 y 12 meses). Edad media 82 años (DE 9), las mujeres representaron el 61,7%. Un total de 135 (11,8%) y 397 (34,6%) pacientes murieron 3 meses y un año después de su inclusión. El sexo masculino, la edad y el índice de masa corporal (IMC) < 20 kg/m2 se asociaron con una mayor mortalidad a los 3, 6 y 12 meses. Bajos niveles de presión arterial sistólica, reducción severa en el filtrado glomerular, malignidad y dosis altas de diuréticos fueron relacionadas con una mortalidad más alta de 6 a 12 meses. El factor de riesgo más importante fue un IMC < 20 kg/m2 (3 meses OR: 3,06; IC 95%: 1,58-5,92; 6 meses OR: 4,42; IC 95%: 2,08-9,38 y 12 meses OR: 3,68; IC 95%: 1,76-7,69). Los varones, la edad avanzada y un IMC disminuido determinaron una mortalidad a corto plazo más alta en pacientes NYHA IV. La baja presión arterial sistólica, la reducción del filtrado glomerular, la malignidad y las dosis altas de diuréticos aumentan el riesgo de mortalidad a medio y largo plazo. Estas variables son fáciles de obtener, y pueden ayudar a decidir las mejores estrategias para afrontar los estadios más avanzados de la enfermedad." @default.
- W2999750613 created "2020-01-23" @default.
- W2999750613 creator A5001279880 @default.
- W2999750613 creator A5004807259 @default.
- W2999750613 creator A5047847326 @default.
- W2999750613 creator A5052984818 @default.
- W2999750613 creator A5067981204 @default.
- W2999750613 creator A5079893147 @default.
- W2999750613 creator A5081582141 @default.
- W2999750613 creator A5083904507 @default.
- W2999750613 date "2020-08-01" @default.
- W2999750613 modified "2023-10-18" @default.
- W2999750613 title "Short-term mortality in end-stage heart failure patients" @default.
- W2999750613 cites W1489755771 @default.
- W2999750613 cites W1968169917 @default.
- W2999750613 cites W1974759427 @default.
- W2999750613 cites W1982252684 @default.
- W2999750613 cites W1995013009 @default.
- W2999750613 cites W1996710573 @default.
- W2999750613 cites W2012701873 @default.
- W2999750613 cites W2017646079 @default.
- W2999750613 cites W2028265881 @default.
- W2999750613 cites W2045532070 @default.
- W2999750613 cites W204895384 @default.
- W2999750613 cites W2051881604 @default.
- W2999750613 cites W2055107847 @default.
- W2999750613 cites W2055663701 @default.
- W2999750613 cites W2057930669 @default.
- W2999750613 cites W2074852127 @default.
- W2999750613 cites W2075421426 @default.
- W2999750613 cites W2103679597 @default.
- W2999750613 cites W2110111033 @default.
- W2999750613 cites W2123157521 @default.
- W2999750613 cites W2126495538 @default.
- W2999750613 cites W2152094400 @default.
- W2999750613 cites W2270038528 @default.
- W2999750613 cites W2307212005 @default.
- W2999750613 cites W2318480619 @default.
- W2999750613 cites W2565720428 @default.
- W2999750613 cites W2583548422 @default.
- W2999750613 cites W4293860347 @default.
- W2999750613 doi "https://doi.org/10.1016/j.aprim.2019.07.019" @default.
- W2999750613 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7393541" @default.
- W2999750613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31932015" @default.
- W2999750613 hasPublicationYear "2020" @default.
- W2999750613 type Work @default.
- W2999750613 sameAs 2999750613 @default.
- W2999750613 citedByCount "4" @default.
- W2999750613 countsByYear W29997506132022 @default.
- W2999750613 countsByYear W29997506132023 @default.
- W2999750613 crossrefType "journal-article" @default.
- W2999750613 hasAuthorship W2999750613A5001279880 @default.
- W2999750613 hasAuthorship W2999750613A5004807259 @default.
- W2999750613 hasAuthorship W2999750613A5047847326 @default.
- W2999750613 hasAuthorship W2999750613A5052984818 @default.
- W2999750613 hasAuthorship W2999750613A5067981204 @default.
- W2999750613 hasAuthorship W2999750613A5079893147 @default.
- W2999750613 hasAuthorship W2999750613A5081582141 @default.
- W2999750613 hasAuthorship W2999750613A5083904507 @default.
- W2999750613 hasBestOaLocation W29997506131 @default.
- W2999750613 hasConcept C126322002 @default.
- W2999750613 hasConcept C151956035 @default.
- W2999750613 hasConcept C164705383 @default.
- W2999750613 hasConcept C187212893 @default.
- W2999750613 hasConcept C2778198053 @default.
- W2999750613 hasConcept C2780221984 @default.
- W2999750613 hasConcept C71924100 @default.
- W2999750613 hasConcept C72563966 @default.
- W2999750613 hasConcept C84393581 @default.
- W2999750613 hasConceptScore W2999750613C126322002 @default.
- W2999750613 hasConceptScore W2999750613C151956035 @default.
- W2999750613 hasConceptScore W2999750613C164705383 @default.
- W2999750613 hasConceptScore W2999750613C187212893 @default.
- W2999750613 hasConceptScore W2999750613C2778198053 @default.
- W2999750613 hasConceptScore W2999750613C2780221984 @default.
- W2999750613 hasConceptScore W2999750613C71924100 @default.
- W2999750613 hasConceptScore W2999750613C72563966 @default.
- W2999750613 hasConceptScore W2999750613C84393581 @default.
- W2999750613 hasIssue "7" @default.
- W2999750613 hasLocation W29997506131 @default.
- W2999750613 hasLocation W29997506132 @default.
- W2999750613 hasLocation W29997506133 @default.
- W2999750613 hasLocation W29997506134 @default.
- W2999750613 hasLocation W29997506135 @default.
- W2999750613 hasLocation W29997506136 @default.
- W2999750613 hasOpenAccess W2999750613 @default.
- W2999750613 hasPrimaryLocation W29997506131 @default.
- W2999750613 hasRelatedWork W1486551637 @default.
- W2999750613 hasRelatedWork W1553859198 @default.
- W2999750613 hasRelatedWork W1992046973 @default.
- W2999750613 hasRelatedWork W2099628268 @default.
- W2999750613 hasRelatedWork W2164703220 @default.
- W2999750613 hasRelatedWork W2383994333 @default.
- W2999750613 hasRelatedWork W44894489 @default.
- W2999750613 hasRelatedWork W55173076 @default.
- W2999750613 hasRelatedWork W588655279 @default.
- W2999750613 hasRelatedWork W642714463 @default.
- W2999750613 hasVolume "52" @default.